Title : The aspartyl protease DDI2 drives adaptation to proteasome inhibition in multiple myeloma.

Pub. Date : 2022 May 19

PMID : 35589686

1 Functional Relationships(s)
Compound Name
Protein Name
1 Finally, we show that partial inhibition of the DDI2-protease domain with the antiviral drug nelfinavir increased bortezomib susceptibility in treated MM cells. Nelfinavir DNA damage inducible 1 homolog 2 Homo sapiens